Companies in the News

11.30.2018

  • Novel investigational RNAi therapeutic for the treatment of chronic hepatitis B virus (HBV) infection

  • Subject dosing commenced

SAN FRANCISCO, Calif. and CAMBRIDGE, Mass. – November 26, 2018 - Vir Biotechnology, Inc. and Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) today announced the initiation...

Please reload